India · Delayed Price · Currency is INR Strides Pharma Science Statistics
Total Valuation
BOM:532531 has a market cap or net worth of INR 79.05 billion. The enterprise value is 95.68 billion.
| Market Cap | 79.05B |
| Enterprise Value | 95.68B |
Important Dates
The last earnings date was Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | Jul 22, 2025 |
Share Statistics
| Current Share Class | 92.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 7.28% |
| Owned by Institutions (%) | 29.54% |
| Float | 56.70M |
Valuation Ratios
The trailing PE ratio is 15.46 and the forward PE ratio is 12.53.
| PE Ratio | 15.46 |
| Forward PE | 12.53 |
| PS Ratio | 1.67 |
| PB Ratio | 2.82 |
| P/TBV Ratio | 5.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.71 |
| EV / Sales | 2.02 |
| EV / EBITDA | 10.88 |
| EV / EBIT | 13.55 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | n/a |
| Interest Coverage | 4.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.49% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 14.32M |
| Profits Per Employee | 1.55M |
| Employee Count | 3,301 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532531 has paid 961.55 million in taxes.
| Income Tax | 961.55M |
| Effective Tax Rate | 15.34% |
Stock Price Statistics
The stock price has increased by +30.17% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +30.17% |
| 50-Day Moving Average | 889.07 |
| 200-Day Moving Average | 854.36 |
| Relative Strength Index (RSI) | 46.75 |
| Average Volume (20 Days) | 33,026 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532531 had revenue of INR 47.26 billion and earned 5.11 billion in profits. Earnings per share was 55.49.
| Revenue | 47.26B |
| Gross Profit | 26.56B |
| Operating Income | 7.04B |
| Pretax Income | 6.27B |
| Net Income | 5.11B |
| EBITDA | 8.51B |
| EBIT | 7.04B |
| Earnings Per Share (EPS) | 55.49 |
Balance Sheet
The company has 2.27 billion in cash and 18.44 billion in debt, with a net cash position of -16.16 billion.
| Cash & Cash Equivalents | 2.27B |
| Total Debt | 18.44B |
| Net Cash | -16.16B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 28.03B |
| Book Value Per Share | 299.06 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.20%, with operating and profit margins of 14.90% and 10.82%.
| Gross Margin | 56.20% |
| Operating Margin | 14.90% |
| Pretax Margin | 13.27% |
| Profit Margin | 10.82% |
| EBITDA Margin | 18.01% |
| EBIT Margin | 14.90% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | 60.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 0.23% |
| Earnings Yield | 6.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |